IS4726A - Meðhöndlun á heilaskemmdum vegna áverka - Google Patents

Meðhöndlun á heilaskemmdum vegna áverka

Info

Publication number
IS4726A
IS4726A IS4726A IS4726A IS4726A IS 4726 A IS4726 A IS 4726A IS 4726 A IS4726 A IS 4726A IS 4726 A IS4726 A IS 4726A IS 4726 A IS4726 A IS 4726A
Authority
IS
Iceland
Prior art keywords
trauma
treatment
damage due
brain damage
brain
Prior art date
Application number
IS4726A
Other languages
English (en)
Inventor
R. Pike Brian
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS4726A publication Critical patent/IS4726A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS4726A 1995-11-06 1998-04-27 Meðhöndlun á heilaskemmdum vegna áverka IS4726A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK123295 1995-11-06
PCT/DK1996/000458 WO1997017074A1 (en) 1995-11-06 1996-11-05 Treatment of traumatic brain injury

Publications (1)

Publication Number Publication Date
IS4726A true IS4726A (is) 1998-04-27

Family

ID=8102484

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4726A IS4726A (is) 1995-11-06 1998-04-27 Meðhöndlun á heilaskemmdum vegna áverka

Country Status (18)

Country Link
EP (1) EP0866706A1 (is)
JP (1) JPH11514654A (is)
KR (1) KR19990067353A (is)
AU (1) AU706594B2 (is)
BG (1) BG63150B1 (is)
BR (1) BR9611396A (is)
CA (1) CA2234824A1 (is)
CZ (1) CZ287441B6 (is)
EA (1) EA000531B1 (is)
HU (1) HUP9901051A2 (is)
IS (1) IS4726A (is)
NO (1) NO982036L (is)
NZ (1) NZ321546A (is)
PL (1) PL326490A1 (is)
SK (1) SK58198A3 (is)
TR (1) TR199800801T2 (is)
WO (1) WO1997017074A1 (is)
ZA (1) ZA969320B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013096A1 (es) * 1997-07-01 2000-12-13 Lundbeck & Co As H Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
RU2266737C1 (ru) * 2004-04-12 2005-12-27 Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Россиской Академии Наук Препарат для лечения геморрагического инсульта и способ лечения геморрагического инсульта
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives

Also Published As

Publication number Publication date
EP0866706A1 (en) 1998-09-30
NZ321546A (en) 2000-12-22
SK58198A3 (en) 1998-10-07
TR199800801T2 (xx) 1998-08-21
AU706594B2 (en) 1999-06-17
ZA969320B (en) 1997-05-30
CZ287441B6 (en) 2000-11-15
AU7490096A (en) 1997-05-29
NO982036L (no) 1998-06-25
EA000531B1 (ru) 1999-10-28
BR9611396A (pt) 1999-07-13
MX9803432A (es) 1998-09-30
KR19990067353A (ko) 1999-08-16
WO1997017074A1 (en) 1997-05-15
CA2234824A1 (en) 1997-05-15
BG102480A (en) 1999-01-29
HUP9901051A2 (hu) 2000-03-28
JPH11514654A (ja) 1999-12-14
EA199800434A1 (ru) 1998-10-29
NO982036D0 (no) 1998-05-05
CZ138998A3 (cs) 1998-10-14
BG63150B1 (bg) 2001-05-31
PL326490A1 (en) 1998-09-28

Similar Documents

Publication Publication Date Title
FI912703A7 (fi) Oleellinen rasvahappokäsittely
FI921232A7 (fi) Siilorehun entsyymaattinen käsittely
FI964874A0 (fi) Vihannesten käsittely
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
DE69618188D1 (de) Kosmetisches hautbehandlungsverfahren
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
DE69500089D1 (de) Behandlung von Geflügel
ATE205365T1 (de) Enzymatische behandlung von kakao
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69622993D1 (de) Sanft behandeltes ungekrepptes durchblasgetrocknetes tissue
FI964339L (fi) Glukaanien entsyymikäsittely
BR9600969A (pt) Método de tratamento de doença inflamatória cardíaca
FI943625A0 (fi) Menetelmiä tulehduksellisten ihotautien hoitamiseksi
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
FI922582A7 (fi) Rasvahappokäsittely
IS4726A (is) Meðhöndlun á heilaskemmdum vegna áverka
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO981866L (no) Terapeutisk anvendelse av hemoglobin for Õ fremme sÕrheling
NO982562D0 (no) Sammensetning for behandling av smerte
DE69308762D1 (de) Behandlung des Muskulschwunds
FI952535A7 (fi) Bentsokinolinonien valmistus
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
KR960025637U (ko) 간격조절이 용이한 콘넥터